Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma
The purpose of the study is to determine the feasibility of using computed tomography-based texture analysis (CTTA) in differentiating between urothelial carcinomas (UC) of the bladder from micropapillary carcinomas (MPC) of the bladder.
Regions of interests (ROIs) of computerized tomography (CT) images of 33 MPCs and 33 UCs were manually segmented and saved. Custom MATLAB code was used to extract voxel information corresponding to the ROI. The segmented tumors were input to a pre-existing radiomics platform with a CTTA panel. A total of 58 texture metrics were extracted using four different texture extraction techniques and statistically analyzed using a Wilcoxon rank-sum test to determine the differences between UCs and MPCs.
Of the 58 texture metrics extracted using the gray level co-occurrence matrix (GLCM) and gray level difference matrix (GLDM), 28 texture metrics were statistically significant (p < 0.05) for differences in tumor textures and 27 texture metrics were statistically significant (p < 0.05) for peritumoral fat textures. The remaining nine metrics extracted using histogram and fast Fourier transform analyses did not show significant differences between the textures of the tumors and their peritumoral fat.
CTTA shows that MPC have a more heterogeneous texture compared to UC. As visual discrimination of MPC from UC from clinical CT scans are difficult, results from this study suggest that tumor heterogeneity extracted using GLCM and GLDM may be a good imaging aid in segregating MPC from UC. This tool can aid clinicians in further sub-classifying bladder cancers on routine imaging, a process which has potential to alter treatment and patient care.
KeywordsMicropapillary carcinoma Urothelial carcinoma Texture analysis Radiomics Bladder cancer
This research was supported by the Radiological Society of North America Medical Student Grant. We would like to acknowledge Fujifilm and all the personnel at the radiomics laboratory at the University of Southern California for their help with this project.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This study has been approved by the appropriate institutional review boards and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
RSNA Medical Student Grant (No. RMS172).
- 1.American Cancer Society (2018) Cancer facts and figures. Atlanta: American Cancer SocietyGoogle Scholar
- 2.Wong MCS, Fung FDH, Leung C, et al. (2018) The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep 8:1129Google Scholar
- 3.Nielsen ME, Smith AB, Meyer AM, et al. (2013) Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer 120:86–95Google Scholar
- 8.Willis DL, Flaig TW, Hansel DE, et al. (2014) Micropapillary bladder cancer: current treatment patterns and review of the literature. Urol Oncol 32(6):826–832Google Scholar
- 9.Amin MB (2009) Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol 22:S96–S118Google Scholar
- 16.Varghese B, Chen F, Hwang D, Cen S, Desai B, Gill I, Duddalwar V. Differentiation of predominantly solid, enhancing lipid-poor renal cell masses using contrast-enhanced computed tomography: evaluating the role of texture in tumor sub-typing. American Journal of Roentgenology (In press)Google Scholar
- 17.Varghese B, Hwang D, Cen S, et al. (2017) Fast fourier transform based analysis of renal masses on contrast-enhanced computed tomography images for grading of tumor. SPIE Proc. doi 10(1117/12):2256871Google Scholar
- 20.Hanania A, Bantis L, Feng Z, et al. (2016) Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget 7(52):85776–85784Google Scholar
- 21.Hodgdon T, McInnes MD, et al. (2015) Can quantitative CT texture analysis be used to differentiate fat-poor renal angiomyolipoma from renal cell carcinoma on unenhanced CT images? Radiology 276(3):787–796Google Scholar
- 22.Wibmer A, Hricak H, Gondo T, et al. (2015) Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol 25(10):2840–2850Google Scholar
- 23.Xu X, Liu Y, Zhang X, et al. (2017) Preoperative prediction of muscular invasiveness of bladder cancer with radiomic features on conventional MRI and its high-order derivative maps. Abdom Radiol (NY) 42(7):1896–1905Google Scholar
- 24.Zhang GM, Sun H, Shi B, Jin ZY, Xue HD (2017) Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma. Abdom Radiol (NY) 42(2):561–568Google Scholar
- 25.Choi HK, Jarkrans T, Bengtsson E, et al. (1997) Image analysis based grading of bladder carcinoma. Comparison of object, texture and graph based methods and their reproducibility. Anal Cell Pathol 15(1):1–18Google Scholar
- 26.Mammen S, Krishna S, Quon M, et al. (2018) Diagnostic accuracy of qualitative and quantitative computed tomography analysis for diagnosis of pathological grade and stage in upper tract urothelial cell carcinoma. J Comput Assist Tomogr 42(2):204–210Google Scholar
- 27.Warrick JI (2017) Clinical significance of histologic variants of bladder cancer. J Natl Compr Cancer Netw 15(10):1268–1274Google Scholar
- 28.Li Z, Liao H, Tan Z, et al. (2017) Micropaillary bladder cancer: a clinico-pathological characterization and treatment analysis. Clin Transl Oncol 19(10):1217–1224Google Scholar
- 29.Samaratunga H, Khoo K (2004) Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 45:55–64Google Scholar